Gensciences is a China-based, globally oriented innovative pharmaceutical company for hemophilia. Relying on our leading long-acting biotechnology platform, we focus on the unmet clinical needs of patients with hemophilia and continue to iteratively develop hemophilia drugs with Global Best-In-Class potential，aiming to help hemophilia patients live a normal life.

Founded in 2019 and headquartered in Nantong, Jiangsu Province, Gensciences has Beijing R&D center, Zhengzhou R&D center, early commercial production base in Shanghai Zhangjiang. 

Updated as of May 27, 2026.